Silymarin suppresses HepG2 hepatocarcinoma cell progression through downregulation of Slit-2/Robo-1 pathway.

Nuriye Ezgi Bektur AykanatSedat KacarSerife KarakayaVarol Sahinturk

Published in: Pharmacological reports : PR (2020)

Silymarin doses showed anti-carcinogenic, anti-metastatic and apoptotic effects in a dose-dependent manner on HepG2 cells through the Slit-2/Robo-1 pathway.

Keyphrases

signaling pathway
squamous cell carcinoma
cell death
small cell lung cancer
single cell
cell proliferation
cell therapy
stem cells
anti inflammatory
bone marrow